While Semaglutide is highly effective for weight loss and managing type 2 diabetes, it may cause some mild to moderate side effects, such as nausea, diarrhea, or stomach discomfort, particularly during the initial weeks of treatment
Originally developed for type 2 diabetes, these medications have shown remarkable efficacy in promoting substantial weight loss and even cardiovascular benefits, leading to widespread use
Ongoing Research Epithalon remains an active area of investigation across aging biology, molecular genetics, and regenerative research
(): 18 HHT patients treated with direct PuraBond application to nasal telangiectasias Improved Epistaxis Severity Scores No adverse events, allergic reactions, or pain reported Less crusting and healthier-appearing mucosa at follow-up (): 985 patients undergoing turbinate reduction, with or without PuraBond Crusting reduced Mucosal re-epithelialisation observed Reliable haemostasis and reduced post-op bleed rates No product-related complications Rather than replacing existing methods, PuraBond is being integrated into ENT practice to help support haemostasis, protect fragile mucosa, and reduce procedural trauma, especially in patients with underlying vascular fragility like HHT